ARCHIVES

Survival Benefit For Vinorelbine-Cisplatin In NSCLC Patient, Phase III Trial Finds

This article is from The Cancer Letter archive.

Vol. 28 No. 8 | August 26, 2005

Download PDF Visit The Full Archive

Related Articles

ACS, In Reorganization, To Emphasize Funds for Young Scientists

January 12, 1996

GM Honors Blackburn, Kuhl, Phelps, Speizer, And Willett

June 8, 2001

Phase III Trial Finds Cabazitaxel Increases Survival Of Advanced Prostate Cancer

March 26, 2010

In Brief: Cancer Control To Push Environmental Research Occupational Hazards; Bailer to Journal Post

May 24, 1974

In Brief: FDA Names DeLap Directory Of Oncology

June 7, 1996

BMT Ok For some Stage IV Breast Cancer, Blues Advisor Say

March 8, 1996